Estimation of the budget impact of the dual dispensing circuit of emicizumab in France: The HemiValue study
The dual dispensing circuit reduces the financial and logistical burdens associated with obtaining emicizumab. These results highlight the importance of innovative dispensing models that aim to ease constraints for patients and their caregivers while working towards greater equity in accessibility.
Authors
- Laurie Fraticelli (ORCID: https://orcid.org/0000-0002-2647-658X)
- V. Chamouard (ORCID: https://orcid.org/0000-0002-4443-1609)
- Henri Leleu (ORCID: https://orcid.org/0000-0003-4930-6767)
- Roula Ajjouri
- Gwladys Touvron
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Hospices Civils de Lyon (FR)
- Roche (France) (FR)
- Laser Expertise (United Kingdom) (GB)
- Hôpital Louis Pradel (FR)
Publication Details
- Journal
- Journal of Epidemiology and Population Health
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.jeph.2025.202975
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00